Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | ASND | JAZZ | ||
| Company | Repligen Corp | Ascendis Pharma ADR | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 145.70 | 137.00 | 122.85 | ||
| High | 150.56 | 141.37 | 124.39 | ||
| Low | 143.96 | 135.61 | 121.37 | ||
| Last | 144.46 | 136.38 | 122.97 | ||
| Change | -2.08 | -1.36 | +0.12 | ||
| % Change | -1.42% | -0.99% | +0.10% | ||
| Volume | 1,581,500 | 690,200 | 1,767,300 | ||
| 20-Day Average Volume | 531,305 | 461,510 | 645,925 | ||
| Previous Close | 146.54 | 137.74 | 122.85 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 150.36 | 133.61 | 122.70 | ||
| 20-Day Raw Stochastic | 18.77% | 72.93% | 48.73% | ||
| 20-Day Relative Strength | 48.20% | 54.58% | 54.79% | ||
| Weighted Alpha | -19.34 | -0.09 | +5.93 | ||
| Today's Opinion | 8% Sell | 24% Buy | 100% Buy | ||
| Previous Opinion | 8% Buy | 24% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.64% since 12/13/24 | +5.01% since 12/13/24 | -0.06% since 12/13/24 | ||
| Low | 143.91 on 12/19/24 | 130.00 on 12/16/24 | 119.14 on 12/19/24 | ||
| High | 161.24 on 12/16/24 | 141.48 on 12/17/24 | 126.23 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +4.00% since 11/20/24 | +9.65% since 11/20/24 | +3.13% since 11/20/24 | ||
| Low | 136.54 on 11/21/24 | 122.43 on 11/21/24 | 117.80 on 12/11/24 | ||
| High | 161.24 on 12/16/24 | 141.48 on 12/17/24 | 128.41 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +1.04% since 09/20/24 | -9.84% since 09/20/24 | +11.02% since 09/20/24 | ||
| Low | 121.52 on 11/15/24 | 118.05 on 11/15/24 | 106.21 on 10/10/24 | ||
| High | 161.24 on 12/16/24 | 151.87 on 09/23/24 | 128.99 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | +20.38% since 06/20/24 | +12.14% since 06/20/24 | +14.54% since 06/20/24 | ||
| Low | 117.63 on 07/09/24 | 111.09 on 09/12/24 | 99.06 on 07/10/24 | ||
| High | 172.65 on 08/01/24 | 155.53 on 09/20/24 | 128.99 on 11/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,093,661 | 8,270,355 | 7,434,152 | ||
| Shares Outstanding, K | 56,027 | 60,642 | 60,455 | ||
| Annual Sales | 638,760,000 | 288,670,000 | 3,834,200,000 | ||
| Annual Net Income | 41,580,000 | -521,070,000 | 414,830,000 | ||
| Last Quarter Sales | 154,870,000 | 63,590,000 | 1,054,970,000 | ||
| Last Quarter Net Income | -650,000 | -109,080,000 | 215,060,000 | ||
| 60-Month Beta | 0.96 | 0.67 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.43 on 11/12/24 | -1.89 on 11/14/24 | 6.61 on 11/06/24 | ||
| Latest Earnings Date | 11/12/24 | 02/05/25 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 106.96 | 0.00 | 7.26 | ||